Day D, Park JJ, Coward J, Markman B, et al. A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer. Br J Cancer 2023 Sep 20. doi: 10.1038/s41416-023-02431.
PMID: 37731023